BRPI0415225A - composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos - Google Patents

composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos

Info

Publication number
BRPI0415225A
BRPI0415225A BRPI0415225-5A BRPI0415225A BRPI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A
Authority
BR
Brazil
Prior art keywords
topical compositions
dermatitis
telmesteìna
treatment
dermatological disorders
Prior art date
Application number
BRPI0415225-5A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of BRPI0415225A publication Critical patent/BRPI0415225A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"COMPOSIçõES TóPICAS COMPREENDENDO TELMESTEìNA PARA O TRATAMENTO DE DISTúRBIOS DERMATOLóGICOS". A presente invenção refere-se a composições tópicas, como cremes e loções, que compreendem ou consistem essencialmente em telmesteína ou seu sal farmaceuticamente aceitável, como ingrediente ativo, e a métodos para seu uso no tratamento de uma variedade de doenças e distúrbios dermatológicos, incluindo dermatite atópica (eczema), dermatite de contato alérgica, dermatite seborróica, dermatite de radiação, psoríase, xerose e atopia.
BRPI0415225-5A 2003-10-09 2004-10-07 composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos BRPI0415225A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2004/011228 WO2005037275A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders

Publications (1)

Publication Number Publication Date
BRPI0415225A true BRPI0415225A (pt) 2006-12-05

Family

ID=34452248

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415225-5A BRPI0415225A (pt) 2003-10-09 2004-10-07 composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos

Country Status (11)

Country Link
US (2) US20070213381A1 (pt)
EP (1) EP1670464B1 (pt)
JP (1) JP2007508264A (pt)
CN (1) CN1863529A (pt)
AT (1) ATE502636T1 (pt)
AU (2) AU2004281521B2 (pt)
BR (1) BRPI0415225A (pt)
CA (1) CA2540859A1 (pt)
DE (1) DE602004031964D1 (pt)
IT (1) ITMI20031941A1 (pt)
WO (1) WO2005037275A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
SG176983A1 (en) * 2009-07-08 2012-02-28 Dermira Canada Inc Tofa analogs useful in treating dermatological disorders or conditions
US20120109042A1 (en) * 2010-10-28 2012-05-03 John Koo Methods of Treating Diseased Tissue
KR101670765B1 (ko) * 2014-09-19 2016-11-01 주식회사 명진뉴텍 글리신계 물질을 포함하는 방부조성물
ES2834905T3 (es) 2017-06-27 2021-06-21 Daxxin AB Composición líquida para lavar el cuero cabelludo y el cabello, o para lavar la piel que comprende piroctona olamina
US10543164B2 (en) 2017-06-30 2020-01-28 The Procter & Gamble Company Deodorant compositions
EP3644950A2 (en) 2017-06-30 2020-05-06 The Procter and Gamble Company Deodorant and antiperspirant compositions
CN110831567B (zh) 2017-06-30 2023-01-24 宝洁公司 包含2-吡啶酚-n-氧化物材料和一种铁螯合剂的毛发护理组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034041T3 (es) * 1988-06-29 1993-04-01 Yason S.R.L Acido n-carbotoxi-4-tiazolidin-carboxilico, proceso para su preparacion y su uso como medicamento.
WO1995000136A1 (en) * 1993-06-18 1995-01-05 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
EP1670464A1 (en) 2006-06-21
AU2008203101A1 (en) 2008-08-07
DE602004031964D1 (de) 2011-05-05
AU2004281521A1 (en) 2005-04-28
ITMI20031941A1 (it) 2005-04-10
US8431601B2 (en) 2013-04-30
ATE502636T1 (de) 2011-04-15
CN1863529A (zh) 2006-11-15
AU2004281521B2 (en) 2008-04-17
US20100130568A1 (en) 2010-05-27
US20070213381A1 (en) 2007-09-13
CA2540859A1 (en) 2005-04-28
WO2005037275A1 (en) 2005-04-28
EP1670464B1 (en) 2011-03-23
JP2007508264A (ja) 2007-04-05

Similar Documents

Publication Publication Date Title
PT1485080E (pt) Utilização de adapaleno para o tratamento de desordens dermatológicas
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
WO2017182885A3 (en) Compositions for the treatment of hyperkeratosis disorders
AR039269A1 (es) Composiciones farmaceuticas topicas para el tratamiento de las dermatitis
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
PH12016500715A1 (en) Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
WO2006068768A3 (en) Methods and compositions for treating conditions
SA519410993B1 (ar) النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية
PT1648484E (pt) Formulações para o tratamento de distúrbios artríticos
MX2024005303A (es) Formulaciones biotensioactivas para su uso en el cuidado de la piel y el tratamiento de heridas.
PL421457A1 (pl) Kompozycja do pielęgnacji skóry
DK1569896T3 (da) Tetrahydronaphthalenderivater
BR112012030006A2 (pt) composições farmacêuticas tópicas
DE602004031964D1 (de) Ndlung von dermatologischen erkrankungen
GEP20135900B (en) Emollient composition
TW200517137A (en) Method for decreasing sebum production
BRPI0417116A (pt) usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
CA2566776A1 (en) Method for ameliorating an inflammatory skin condition
MX2023010918A (es) Metodos y composiciones para el tratamiento de enfermedades oculares.
SI1893237T1 (sl) Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine
WO2012001082A3 (en) Moisturizing composition with spf 30
WO2009036751A3 (de) Kosmetische oder dermatologische zusammensetzung zur topischen verwendung
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.